SilverOak Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$956K Buy
797
+2
+0.3% +$2.04K 0.12% 61
2026
Q1
$731K Buy
795
+40
+5% +$40.6K 0.12% 59
2025
Q4
$811K Sell
755
-8
-1% -$7.65K 0.13% 54
2025
Q3
$582K Sell
763
-16
-2% -$11.9K 0.1% 63
2025
Q2
$607K Buy
779
+147
+23% +$114K 0.11% 60
2025
Q1
$522K Hold
632
0.11% 58
2024
Q4
$488K Buy
632
+5
+0.8% +$4.14K 0.11% 59
2024
Q3
$555K Buy
627
+233
+59% +$209K 0.12% 57
2024
Q2
$357K Buy
394
+3
+0.8% +$2.4K 0.09% 69
2024
Q1
$304K Buy
+391
New +$278K 0.08% 69

Other funds holding LLY

SilverOak Wealth Management's LLY Position: Q2 2026 in Review

SilverOak Wealth Management increased its Eli Lilly (LLY) stake by 0.25% in Q2 2026, buying an estimated $2.04K and bringing the position to 797 shares worth $956K. The position accounts for 0.12% of the portfolio, ranked #61.

SilverOak Wealth Management first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • SilverOak Wealth Management held 797 shares of Eli Lilly worth $956K as of Q2 2026.
  • SilverOak Wealth Management bought 2 Eli Lilly shares in Q2 2026, an estimated $2.04K.
  • Eli Lilly made up 0.12% of SilverOak Wealth Management's portfolio in Q2 2026, its #61 holding.
  • SilverOak Wealth Management first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on SilverOak Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.